Results 91 to 100 of about 51,653 (260)

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

TUMORES CARCINOIDES

open access: yes, 2009
En 1907 Obemdorfer llamó "Karzinoides" a tumores malignos del tracto gastrointestinal que exhiben un patrón de crecimiento semejante a los carcinomas pero con un comportamiento menos agresivo.
Díaz Brito, Jack Antonio   +1 more
core   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Tumores bilaterales de testículo [PDF]

open access: yes, 2007
Objetivos: Estudiar la incidencia y características de los tumores bilaterales de testículo. Material y métodos: Se realizó un estudio retrospectivo sobre una base de datos de tumores 98 testiculares tratados en nuestro servicio entre los años 1979 y ...
Paños Lozano,P.   +5 more
core   +1 more source

Tumores quísticos del pancreas [PDF]

open access: yes, 2014
Los tumores quísticos del páncreas constituyen un grupo heterogéneo de neoplasias poco frecuentes, representan el 1 % de los tumores pancreáticos y el 15 % de las lesiones quísticas pancreáticas, que incluye los tumores serosos, mucinosos, las neoplasias
Flores Miranda, Enrique   +3 more
core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Tumores de células redondas, pequeñas y azules

open access: yes, 2001
Los tumores de células pequeñas, redondas y azules, constituyen un desafío diagnóstico para el patólogo quien no sólo debe conocer la larga lista de estos tumores con este patrón sino que debe saber, cuándo, cómo y la verdadera utilidad e impacto de las ...
Germán Barbosa Serrano   +3 more
core  

Tumores cardíacos primarios [PDF]

open access: yes, 2013
Introducción: los tumores cardíacos primarios son aquellos que se originan en Miocardio o Pericardio. El 90% son benignos, no son invasivos, pero debido a su localización pueden provocar alteraciones hemodinámicas graves y arrítmias.
Luis Raúl Martínez González   +7 more
core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy